(Q34540557)

2 August 2017

1 reference

title

Nanoparticle technology for drug delivery across the blood-brain barrier (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

Lockman PR

1

1 reference

2 August 2017

Mumper RJ

series ordinal

2

1 reference

2 August 2017

Khan MA

series ordinal

3

1 reference

2 August 2017

Allen DD

series ordinal

4

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Drug Development and Industrial Pharmacy

2 August 2017

1 reference

2 August 2017

28

1 reference

2 August 2017

1-13

1 reference

2 August 2017

1

1 reference

Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study

2 August 2017

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Regional cerebrovascular permeability to [14C]sucrose after osmotic opening of the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Pathway across blood-brain barrier opened by the bradykinin agonist, RMP-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Drug streaming during intra-arterial chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Nanoparticle technology for delivery of drugs across the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Nanoparticulate systems for brain delivery of drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Targeted delivery of low dose doxorubicin hydrochloride administered via magnetic albumin microspheres in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FDDC-120001481

21 January 2018

Identifiers

DOI

10.1081/DDC-120001481

1 reference

2 August 2017

1 reference